Skip to main content

Table 3 Prevalence (%) and 95% confidence intervals (CI) of multisite musculoskeletal symptoms (MS) lasting at least 30 days during the past 12 months among men and women

From: Prevalence of multisite musculoskeletal symptoms: a French cross-sectional working population-based study

Multisite MS: n (%) CI

Men (N = 2,162)

Women (N = 1,548)

By genre**

370

(17.1)

15.5-18.7

346

(22.4)

20.3-24.4

By age group (test for linear trend) §§‡

16-29 years

48

(9.3)

6.8-11.9

43

(11.9)

8.6-15.3

30-39 years

97

(14.9)

12.2-17.7

72

(16.8)

13.2-20.3

40-49 years

130

(21.2)

18.0-24.5

132

(27.1)

23.2-31.1

50-63 years

93

(24.5)

20.2-28.9

99

(36.7)

30.9-42.4

By occupational category§

Managers and professionals

22

(10.5)

6.3-14.6

19

(24.4)

14.8-33.9

Associate professionals/technicians

86

(15.9)

12.8-19.0

54

(18.7)

14.2-23.2

Employees

30

(16.0)

10.7-21.2

170

(21.3)

18.5-24.1

Skilled and unskilled workers

232

(19.2)

17.0-21.4

102

(27.1)

22.6-31.5

By economic activity†

Service industries

170

(15.8)

13.6-17.9

228

(20.9)

18.5-23.3

Meat and manufacturing industries

160

(18.6)

16.0-21.2

108

(27.0)

22.6-31.3

Construction

34

(18.0)

12.5-23.5

2

(8.0)

1.0-26.0#

Agriculture

5

(16.1)

3.2-29.1

6

(24.0)

7.3-40.7

  1. Significant differences between men and women: * p < 0.01, ** p < 0.0001.
  2. Significant differences among men: § p < 0.01, §§ p < 0.0001.
  3. Significant differences among women: † p < 0.01, ‡ p < 0.0001.
  4. # Estimation of CI with Fisher’s exact method (np or nq < 5).